Densitas, a leader in artificial intelligence solutions for breast cancer screening, has entered into a strategic partnership with Intelerad Medical Systems, a prominent provider of medical imaging software and services.
This collaboration aims to bolster clinical decision-making, enhance operational efficiency, reduce costs, and improve the quality of mammography while ensuring compliance with MQSA EQUIP standards. Densitas will extend its intelliMammo AI platform to Intelerad's network of 2,500 healthcare organisations.
The intelliMammo platform offers AI-driven insights for breast cancer screening providers, facilitating better patient care, operational improvements, and adherence to regulatory standards. The platform includes AI engines for breast density assessment, mammography positioning quality evaluation, and breast cancer risk assessments.
This partnership strengthens the focus on women's health and empowers healthcare providers with advanced decision-making support and superior mammography quality solutions.
Click here to read the original news story.